Aug 28, 2023

Change of Company Secretary (ASX Announcement)

Melbourne, Australia; 28 August 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) today announces, in accordance with ASX Listing Rule 3.16.1, that Tracy Weimar has resigned as Company Secretary, a role that was conducted for an interim period.

Mr Justin Cahill, Starpharma’s Chief Financial Officer and Company Secretary, continues as the person responsible for communication with ASX under ASX Listing Rule 12.6.

View or download the ASX Announcement here.

 This contains certain forward-looking statements.